There is now extensive literature demonstrating that BDNF/TrkB signaling is involved in regulating several aspects of tumor cell physiology, including neovascularization [19], tumor proliferation [20], epithelial-to-mesenchymal transition [21], apoptosis resistance [22], and cytotoxic drug resistance [23]. Here, NTRK2 is linked to neoplasm.